These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 16144328)

  • 1. [The tissue distribution in mice and pharmacokinetics in rabbits of oridonin-solid lipid nanoparticles].
    Zhang DR; Ren TC; Lou HX; Xing J
    Yao Xue Xue Bao; 2005 Jun; 40(6):573-6. PubMed ID: 16144328
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetic behaviors and oral bioavailability of oridonin in rat plasma.
    Xu W; Sun J; Zhang TT; Ma B; Cui SM; Chen DW; He ZG
    Acta Pharmacol Sin; 2006 Dec; 27(12):1642-6. PubMed ID: 17112421
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Studies on pharmacokinetics and tissue distribution of oridonin nanosuspensions.
    Gao L; Zhang D; Chen M; Duan C; Dai W; Jia L; Zhao W
    Int J Pharm; 2008 May; 355(1-2):321-7. PubMed ID: 18242896
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vivo studies on the oridonin-loaded nanostructured lipid carriers.
    Zheng D; Dai W; Zhang D; Duan C; Jia L; Liu Y; Zhang Q
    Drug Deliv; 2012 Aug; 19(6):286-91. PubMed ID: 22928767
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Injectable actarit-loaded solid lipid nanoparticles as passive targeting therapeutic agents for rheumatoid arthritis.
    Ye J; Wang Q; Zhou X; Zhang N
    Int J Pharm; 2008 Mar; 352(1-2):273-9. PubMed ID: 18054182
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An HPLC method for determination of oridonin in rabbits using isopsoralen as an internal standard and its application to pharmacokinetic studies for oridonin-loaded nanoparticles.
    Mei Y; Xu J; Zhao J; Feng N; Liu Y; Wei L
    J Chromatogr B Analyt Technol Biomed Life Sci; 2008 Jun; 869(1-2):138-41. PubMed ID: 18514594
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of stealth liposomes on pharmacokinetics, tissue distribution and anti-tumor activity of oridonin.
    Wang C; Wei Y; Yu L; Zhang L
    PDA J Pharm Sci Technol; 2009; 63(5):409-16. PubMed ID: 20158047
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stealth tanshinone IIA-loaded solid lipid nanoparticles: effects of poloxamer 188 coating on in vitro phagocytosis and in vivo pharmacokinetics in rats.
    Zhang WL; Liu JP; Liu XX; Chen ZQ
    Yao Xue Xue Bao; 2009 Dec; 44(12):1421-8. PubMed ID: 21348419
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Determination of oridonin and rosemarinic acid in Rabdosia rubescens by HPLC].
    Wang K; Zhang ZQ
    Zhong Yao Cai; 2007 Nov; 30(11):1396-8. PubMed ID: 18323207
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preparation and evaluation of self-microemulsifying drug delivery system of oridonin.
    Zhang P; Liu Y; Feng N; Xu J
    Int J Pharm; 2008 May; 355(1-2):269-76. PubMed ID: 18242895
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Galactosylated chitosan nanoparticles for hepatocyte-targeted delivery of oridonin.
    Zheng D; Duan C; Zhang D; Jia L; Liu G; Liu Y; Wang F; Li C; Guo H; Zhang Q
    Int J Pharm; 2012 Oct; 436(1-2):379-86. PubMed ID: 22732673
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sustained-release hydroxycamptothecin polybutylcyanoacrylate nanoparticles as a liver targeting drug delivery system.
    Sun X; Wu F; Lu W; Zhang ZR
    Pharmazie; 2004 Oct; 59(10):791-4. PubMed ID: 15544059
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Study on the inclusion of oridonin-beta-cyclodextrin].
    Zhang Y; Kou X; Lu J; Wang G
    Zhong Yao Cai; 1999 Apr; 22(4):204-5. PubMed ID: 12575108
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oridonin-loaded poly(epsilon-caprolactone)-poly(ethylene oxide)-poly(epsilon-caprolactone) copolymer nanoparticles: preparation, characterization, and antitumor activity on mice with transplanted hepatoma.
    Feng N; Wu P; Li Q; Mei Y; Shi S; Yu J; Xu J; Liu Y; Wang Y
    J Drug Target; 2008 Jul; 16(6):479-85. PubMed ID: 18604660
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Preparation and liver targeting of floxuridinyl dibutyrate solid lipid nanoparticles].
    Li JJ; Yang GD; Wang HY; Zhang SQ
    Yao Xue Xue Bao; 2008 Jul; 43(7):761-5. PubMed ID: 18819483
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preparation and characteristics of oridonin-loaded nanostructured lipid carriers as a controlled-release delivery system.
    Dai W; Zhang D; Duan C; Jia L; Wang Y; Feng F; Zhang Q
    J Microencapsul; 2010 May; 27(3):234-41. PubMed ID: 20113167
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Determination of oridonin in rat plasma by reverse-phase high-performance liquid chromatography.
    Ge J; You-Wei W; Xiao-Cong L; Ji-Yue C
    J Pharm Biomed Anal; 2007 Jan; 43(2):793-7. PubMed ID: 17011736
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Mechanism of downregulation of apoptosis by autophagy induced by oridonin in HeLa cells].
    Cui Q; Tashiro S; Onodera S; Ikejima T
    Yao Xue Xue Bao; 2007 Jan; 42(1):35-9. PubMed ID: 17520804
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Change of Bcl-2 expression and telomerase during apoptosis induced by oridonin on human hepatocelluar carcinoma cells].
    Zhang JF; Chen GH; Lu MQ; Li H; Cai CJ; Yang Y
    Zhongguo Zhong Yao Za Zhi; 2006 Nov; 31(21):1811-4. PubMed ID: 17260801
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Studies on the oridonin-loaded poly(D,L-lactic acid) nanoparticles in vitro and in vivo.
    Xing J; Zhang D; Tan T
    Int J Biol Macromol; 2007 Jan; 40(2):153-8. PubMed ID: 16901536
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.